Qlarity gets FDA OK for MRI-guided breast biopsy software plugin

By AuntMinnie.com staff writers

November 19, 2019 -- Medical artificial intelligence (AI) software developer Qlarity Imaging has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its QuantX MRI guidance breast biopsy software plugin.

The MRI guidance breast biopsy software plugin is the latest addition to Qlarity's QuantX breast imaging computer-aided diagnosis platform. The plugin allows radiologists to plan MRI-guided breast interventions such as breast biopsy. It uses information from MR images to calculate the precise location and depth of a particular lesion and then recommends the ideal location and depth for inserting a biopsy needle.

Qlarity Imaging is a subsidiary of Paragon Biosciences.

Qlarity
QuantX MRI guidance breast biopsy software plugin. Image courtesy of Qlarity.

Copyright © 2019 AuntMinnie.com
 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: